Nina Isoherranen
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 61
- Transplantation top 1%
- Biochemistry top 1%
- Antioxidant Activity and Oxidative Stress 28
-
- Pharmacological Effects and Toxicity Studies 25
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 61
-
- Retinoids in leukemia and cellular processes 50
-
- Drug Transport and Resistance Mechanisms 40
-
- Estrogen and related hormone effects 23
-
- Epilepsy research and treatment 13
-
- Computational Drug Discovery Methods 11
- Co-authors
- Kenneth E. ThummelJennifer E. SagerWendel L. NelsonKent L. KunzeIsabelle Ragueneau‐MajlessiGuo ZhongStefan SobackJingjing Yu
- Journals
- Drug Metabolism and Disposition (30 papers)Clinical and Translational Science (9 papers)Clinical Pharmacology & Therapeutics (9 papers)
- Partner nations
- United StatesIsraelFinland
In The Last Decade
Nina Isoherranen
166 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Pharmacology 1.8k
- Transplantation 256
- Biochemistry 477
- Pediatrics, Perinatology and Child Health 1.2k
- Pharmacology 754
Countries citing papers authored by Nina Isoherranen
This map shows the geographic impact of Nina Isoherranen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Isoherranen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Isoherranen more than expected).
Fields of papers citing papers by Nina Isoherranen
This network shows the impact of papers produced by Nina Isoherranen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Isoherranen. The network helps show where Nina Isoherranen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nina Isoherranen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 43 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 27 | |
| 14 | 2019 | 9 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 22 | |
| 17 | 2018 | 20 | |
| 18 | 2017 | 39 | |
| 19 | 2015 | 39 | |
| 20 | 2014 | 64 |
About Nina Isoherranen
Nina Isoherranen is a scholar working on Pharmacology, Biochemistry and Pediatrics, Perinatology and Child Health, having authored 167 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (61 papers), Retinoids in leukemia and cellular processes (50 papers), Drug Transport and Resistance Mechanisms (40 papers), Antioxidant Activity and Oxidative Stress (28 papers), Pharmacological Effects and Toxicity Studies (25 papers), Estrogen and related hormone effects (23 papers), Epilepsy research and treatment (13 papers) and Computational Drug Discovery Methods (11 papers). The work is most often cited by research in Pharmacology (1.8k citations), Transplantation (256 citations) and Biochemistry (477 citations). Nina Isoherranen has collaborated with scholars based in United States, Israel and Finland. Frequent co-authors include Kenneth E. Thummel, Jennifer E. Sager, Wendel L. Nelson, Kent L. Kunze, Isabelle Ragueneau‐Majlessi, Guo Zhong, Stefan Soback, Jingjing Yu, Justin D. Lutz and Samuel L.M. Arnold. Their work appears in journals such as Drug Metabolism and Disposition, Clinical and Translational Science, Clinical Pharmacology & Therapeutics, Biochemical Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.